Global Gastrointestinal Therapeutics and Diagnostics Market Insights and Forecast to 2028

Report ID: 1802814 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Diagnostics
        1.2.3 Therapeutics
    1.3 Market by Application
        1.3.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Gastroenteritis
        1.3.3 GI Bleeding
        1.3.4 Irritable Bowel Syndrome
        1.3.5 Peptic Ulcer Disease (PUD)
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Perspective (2017-2028)
    2.2 Gastrointestinal Therapeutics and Diagnostics Growth Trends by Region
        2.2.1 Gastrointestinal Therapeutics and Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Gastrointestinal Therapeutics and Diagnostics Market Dynamics
        2.3.1 Gastrointestinal Therapeutics and Diagnostics Industry Trends
        2.3.2 Gastrointestinal Therapeutics and Diagnostics Market Drivers
        2.3.3 Gastrointestinal Therapeutics and Diagnostics Market Challenges
        2.3.4 Gastrointestinal Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue
        3.1.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gastrointestinal Therapeutics and Diagnostics Revenue
    3.4 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio
        3.4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics and Diagnostics Revenue in 2021
    3.5 Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Area Served
    3.6 Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
    3.7 Date of Enter into Gastrointestinal Therapeutics and Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Type
    4.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028)
5 Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Application
    5.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size (2017-2028)
    6.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type
        6.2.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022)
        6.2.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2023-2028)
        6.2.3 North America Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2017-2028)
    6.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application
        6.3.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022)
        6.3.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2023-2028)
        6.3.3 North America Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2017-2028)
    6.4 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country
        6.4.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2017-2022)
        6.4.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size (2017-2028)
    7.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type
        7.2.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022)
        7.2.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2023-2028)
        7.2.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2017-2028)
    7.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application
        7.3.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022)
        7.3.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2023-2028)
        7.3.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2017-2028)
    7.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country
        7.4.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2017-2022)
        7.4.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size (2017-2028)
    9.2 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Type
        9.2.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022)
        9.2.2 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2023-2028)
        9.2.3 Latin America Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2017-2028)
    9.3 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Application
        9.3.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022)
        9.3.2 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2023-2028)
        9.3.3 Latin America Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2017-2028)
    9.4 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country
        9.4.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2017-2022)
        9.4.2 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Introduction
        11.1.4 Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Developments
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Details
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Introduction
        11.2.4 AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022)
        11.2.5 AstraZeneca Recent Developments
    11.3 Eisai
        11.3.1 Eisai Company Details
        11.3.2 Eisai Business Overview
        11.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Introduction
        11.3.4 Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022)
        11.3.5 Eisai Recent Developments
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Introduction
        11.4.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Developments
    11.5 Salix Pharmaceuticals
        11.5.1 Salix Pharmaceuticals Company Details
        11.5.2 Salix Pharmaceuticals Business Overview
        11.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Introduction
        11.5.4 Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022)
        11.5.5 Salix Pharmaceuticals Recent Developments
    11.6 Takeda Pharmaceutical Company
        11.6.1 Takeda Pharmaceutical Company Company Details
        11.6.2 Takeda Pharmaceutical Company Business Overview
        11.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Introduction
        11.6.4 Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022)
        11.6.5 Takeda Pharmaceutical Company Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Diagnostics
    Table 3. Key Players of Therapeutics
    Table 4. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2017-2022)
    Table 8. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2023-2028)
    Table 10. Gastrointestinal Therapeutics and Diagnostics Market Trends
    Table 11. Gastrointestinal Therapeutics and Diagnostics Market Drivers
    Table 12. Gastrointestinal Therapeutics and Diagnostics Market Challenges
    Table 13. Gastrointestinal Therapeutics and Diagnostics Market Restraints
    Table 14. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Players (2017-2022)
    Table 16. Global Top Gastrointestinal Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2021)
    Table 17. Ranking of Global Top Gastrointestinal Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
    Table 21. Date of Enter into Gastrointestinal Therapeutics and Diagnostics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2017-2022)
    Table 25. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2023-2028)
    Table 27. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Application (2017-2022)
    Table 29. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Application (2023-2028)
    Table 31. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Abbott Laboratories Company Details
    Table 62. Abbott Laboratories Business Overview
    Table 63. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product
    Table 64. Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 65. Abbott Laboratories Recent Developments
    Table 66. AstraZeneca Company Details
    Table 67. AstraZeneca Business Overview
    Table 68. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product
    Table 69. AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 70. AstraZeneca Recent Developments
    Table 71. Eisai Company Details
    Table 72. Eisai Business Overview
    Table 73. Eisai Gastrointestinal Therapeutics and Diagnostics Product
    Table 74. Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 75. Eisai Recent Developments
    Table 76. Johnson & Johnson Company Details
    Table 77. Johnson & Johnson Business Overview
    Table 78. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product
    Table 79. Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 80. Johnson & Johnson Recent Developments
    Table 81. Salix Pharmaceuticals Company Details
    Table 82. Salix Pharmaceuticals Business Overview
    Table 83. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product
    Table 84. Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 85. Salix Pharmaceuticals Recent Developments
    Table 86. Takeda Pharmaceutical Company Company Details
    Table 87. Takeda Pharmaceutical Company Business Overview
    Table 88. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product
    Table 89. Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 90. Takeda Pharmaceutical Company Recent Developments
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Diagnostics Features
    Figure 3. Therapeutics Features
    Figure 4. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Application: 2021 VS 2028
    Figure 5. Gastroenteritis Case Studies
    Figure 6. GI Bleeding Case Studies
    Figure 7. Irritable Bowel Syndrome Case Studies
    Figure 8. Peptic Ulcer Disease (PUD) Case Studies
    Figure 9. Others Case Studies
    Figure 10. Gastrointestinal Therapeutics and Diagnostics Report Years Considered
    Figure 11. Global Gastrointestinal Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Gastrointestinal Therapeutics and Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region: 2021 VS 2028
    Figure 14. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Players in 2021
    Figure 15. Global Top Gastrointestinal Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue in 2021
    Figure 17. North America Gastrointestinal Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 19. North America Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 20. North America Gastrointestinal Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 21. United States Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Gastrointestinal Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 27. Germany Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Share by Region (2017-2028)
    Figure 37. China Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 47. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 53. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Abbott Laboratories Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022)
    Figure 57. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022)
    Figure 58. Eisai Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022)
    Figure 60. Salix Pharmaceuticals Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022)
    Figure 61. Takeda Pharmaceutical Company Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
AstraZeneca
Eisai
Johnson & Johnson
Salix Pharmaceuticals
Takeda Pharmaceutical Company
Frequently Asked Questions
Gastrointestinal Therapeutics and Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastrointestinal Therapeutics and Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastrointestinal Therapeutics and Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gauze Bandages

Gauze Bandages market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More

Gauze Swabs

Gauze Swabs market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More